tiprankstipranks
ArriVent BioPharma, Inc. (AVBP)
NASDAQ:AVBP
US Market

ArriVent BioPharma, Inc. (AVBP) Similar Stocks

Compare
26 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
ArriVent BioPharma, Inc.
$21.96
$742.35M
-3.49%
2 Buy
0 Hold
0 Sell
Moderate Buy
Fate Therapeutics
$0.95
$117.31M
-86.29%
2 Buy
1 Hold
0 Sell
Moderate Buy
Sorrento Therapeutics
$0.01
$441.02K
-50.00%
Aldeyra Therapeutics
$6.17
$368.40M
57.00%
3 Buy
0 Hold
0 Sell
Strong Buy
Atara Biotherapeutics
$7.13
$41.07M
-61.99%
1 Buy
3 Hold
0 Sell
Hold
Adaptimmune Therapeutics
$0.48
$123.85M
-66.85%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AVBP
ArriVent BioPharma, Inc.
21.96
1.71
8.44%
FATE
Fate Therapeutics
0.95
-7.03
-88.10%
SRNE
Sorrento Therapeutics
0.01
-0.02
-66.67%
ALDX
Aldeyra Therapeutics
6.17
2.24
57.00%
ATRA
Atara Biotherapeutics
7.13
-10.32
-59.14%
ADAP
Adaptimmune Therapeutics
0.48
-1.23
-71.93%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis